toxicological profile for malathion - Agency for Toxic Substances and ...
toxicological profile for malathion - Agency for Toxic Substances and ...
toxicological profile for malathion - Agency for Toxic Substances and ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
MALATHION 146<br />
3. HEALTH EFFECTS<br />
plasma cholinesterase is present in about 3% of the population, <strong>and</strong> there<strong>for</strong>e, these individuals are<br />
particularly sensitive to the effects of organophosphate pesticides.<br />
As detailed in Section 3.9, subjects exposed to other pesticides that also inhibit carboxylesterase activity,<br />
enzyme responsible <strong>for</strong> the detoxification of <strong>malathion</strong> in mammalian species, may be at higher risk of<br />
exceeding thresholds <strong>for</strong> the manifestation of adverse effects when exposed simultaneously to <strong>malathion</strong>.<br />
3.11 METHODS FOR REDUCING TOXIC EFFECTS<br />
This section will describe clinical practice <strong>and</strong> research concerning methods <strong>for</strong> reducing toxic effects of<br />
exposure to <strong>malathion</strong>. However, because some of the treatments discussed may be experimental <strong>and</strong><br />
unproven, this section should not be used as a guide <strong>for</strong> treatment of exposures to <strong>malathion</strong>. When<br />
specific exposures have occurred, poison control centers <strong>and</strong> medical toxicologists should be consulted<br />
<strong>for</strong> medical advice. The following texts provide specific in<strong>for</strong>mation about treatment following exposures<br />
to organophosphate pesticides:<br />
Goldfrank LR, Flomenbaum NE, Lewin NA, et al., eds. 1998. Goldfrank's toxicologic emergencies. 6 th<br />
ed. Stam<strong>for</strong>d, CT: Appleton <strong>and</strong> Lange.<br />
Haddad LM, Shannon MW, Winchester JF, eds. 1998. Clinical management of poisoning <strong>and</strong> drug<br />
overdose. 3 rd ed. Philadelphia, PA: WB Saunders Company.<br />
Viccellio P, Bania T, Brent J, et al., eds. 1998. Emergency toxicology. 2 nd ed. Philadelphia, PA:<br />
Lippincott-Raven Publishers.<br />
3.11.1 Reducing Peak Absorption Following Exposure<br />
The following in<strong>for</strong>mation was extracted from the books listed above; specific chapters were written by<br />
Aaron <strong>and</strong> Howl<strong>and</strong> (1998), Carlton et al. (1998), <strong>and</strong> Osmundsen (1998). Following dermal<br />
contamination with organophosphates, most texts recommend washing the skin with copious amounts of<br />
soap <strong>and</strong> water, which may be followed by a second washing with ethyl alcohol. Ocular exposures<br />
should have copious eye irrigation with normal saline or lactated Ringer’s solution (Aaron <strong>and</strong> Howl<strong>and</strong><br />
1998). Contaminated clothing including leather garments should be destroyed. After oral ingestion,<br />
activated charcoal is recommended <strong>for</strong> many organophosphates, although Carlton et al. (1998) note that it<br />
may lack efficiency with some organophosphates such as <strong>for</strong> <strong>malathion</strong>. Osmundsen (1998) points out<br />
that Ipecac should not be used <strong>for</strong> organophosphate poisoning. Cathartics may be unnecessary as